Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Venous Thromboembolism After Intraventricular Hemorrhage: Results From the CLEAR III Trial

Venous Thromboembolism After Intraventricular Hemorrhage: Results From the CLEAR III Trial AbstractBACKGROUNDVenous thromboembolism (VTE) after intracerebral hemorrhage is well studied, but data on patients with spontaneous intraventricular hemorrhage (IVH) are limited.OBJECTIVETo study the factors associated with VTE, association between VTE and clinical outcomes in IVH, and safety of VTE chemoprophylaxis in IVH treated with intraventricular catheters and thrombolysis.METHODSRetrospective cohort study of patients enrolled in the CLEAR III trial, a multicenter, randomized trial comparing external ventricular drainage, with administration of intraventricular alteplase vs placebo, for obstructive IVH. Predictor variable was incident VTE in the first 30 d. Outcome measures were factors associated with VTE, and death/severe disability (modified Rankin Score 4-6) at 6 mo.RESULTSOf the 500 patients with IVH, VTE occurred in 59 patients (11.8%) within the first 30 d. VTE chemoprophylaxis was initiated in 412 (82.4%) patients, but before VTE diagnosis in only 401 (80.2%) at median of 4 d (interquartile range, 1-8) from IVH onset, and was not associated with intracranial bleeding or catheter tract hemorrhage. In the multivariate logistic regression analysis, infection within 30 d (odds ratio, 1.80; confidence interval, 1.03-3.17) was significantly associated with higher odds of VTE occurrence. Starting VTE chemoprophylaxis after 72 h was additionally associated with VTE occurrence after the first week.CONCLUSIONInfection and delay in timely initiation of VTE chemoprophylaxis were associated with VTE occurrence. VTE chemoprophylaxis in IVH appears safe and should not be delayed beyond standard care policies for ICH including when intraventricular catheter placement and thrombolytic therapy are performed. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neurosurgery Oxford University Press

Venous Thromboembolism After Intraventricular Hemorrhage: Results From the CLEAR III Trial

,
Neurosurgery , Volume 84 (3) – Mar 1, 2019
Download PDF
8 pages

Loading next page...
 
/lp/ou_press/venous-thromboembolism-after-intraventricular-hemorrhage-results-from-iru0tQJ0RP
Publisher
Oxford University Press
Copyright
Copyright © 2018 by the Congress of Neurological Surgeons
ISSN
0148-396X
eISSN
1524-4040
DOI
10.1093/neuros/nyy189
Publisher site
See Article on Publisher Site

Abstract

AbstractBACKGROUNDVenous thromboembolism (VTE) after intracerebral hemorrhage is well studied, but data on patients with spontaneous intraventricular hemorrhage (IVH) are limited.OBJECTIVETo study the factors associated with VTE, association between VTE and clinical outcomes in IVH, and safety of VTE chemoprophylaxis in IVH treated with intraventricular catheters and thrombolysis.METHODSRetrospective cohort study of patients enrolled in the CLEAR III trial, a multicenter, randomized trial comparing external ventricular drainage, with administration of intraventricular alteplase vs placebo, for obstructive IVH. Predictor variable was incident VTE in the first 30 d. Outcome measures were factors associated with VTE, and death/severe disability (modified Rankin Score 4-6) at 6 mo.RESULTSOf the 500 patients with IVH, VTE occurred in 59 patients (11.8%) within the first 30 d. VTE chemoprophylaxis was initiated in 412 (82.4%) patients, but before VTE diagnosis in only 401 (80.2%) at median of 4 d (interquartile range, 1-8) from IVH onset, and was not associated with intracranial bleeding or catheter tract hemorrhage. In the multivariate logistic regression analysis, infection within 30 d (odds ratio, 1.80; confidence interval, 1.03-3.17) was significantly associated with higher odds of VTE occurrence. Starting VTE chemoprophylaxis after 72 h was additionally associated with VTE occurrence after the first week.CONCLUSIONInfection and delay in timely initiation of VTE chemoprophylaxis were associated with VTE occurrence. VTE chemoprophylaxis in IVH appears safe and should not be delayed beyond standard care policies for ICH including when intraventricular catheter placement and thrombolytic therapy are performed.

Journal

Neurosurgery – Oxford University Press

Published: Mar 1, 2019

References

  • Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis
  • Spontaneous intracerebral hemorrhage
  • Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial
  • Venous thromboembolism in patients with ischemic and hemorrhagic stroke
  • Risk of thromboembolism following acute intracerebral hemorrhage
  • Deep venous thrombosis after acute intracerebral hemorrhage
  • Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity
  • Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage
  • Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage
  • Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial
  • A multicenter, randomized, double-blinded, placebo-controlled phase iii study of clot lysis evaluation of accelerated resolution of intraventricular hemorrhage (clear iii)
  • Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial
  • Triggers of hospitalization for venous thromboembolism
  • The effect of inflammation on coagulation and vice versa
  • The impact of the inflammatory response on coagulation
  • Ten-year temporal trends in medical complications after acute intracerebral hemorrhage in the United States
  • Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage
  • Guidelines for the management of spontaneous intracerebral hemorrhage
  • Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the neurocritical care society
  • Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population
  • What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients
  • Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature
  • Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement
  • A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III)